Inhibitory effects and mechanism of tanshinone II A on proliferation of rat aortic smooth muscle cells

Zhongguo Zhongyao Zazhi

Volumn 33, Issue 17, 2008, Pages 2146-2150

  Li, Xin ^a,b   Du, Jun rong ^b   Bo, Bai ^b   Yu, Yan ^b   Zheng, Xiao yuan ^b   Yang, Fang ^b   Zheng, Hu ^b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

c fos; Cell cycle; MAPK; Tanshinone II A; Vascular smooth muscle cells

Indexed keywords

PHENANTHRENE DERIVATIVE; PROTEIN C FOS; TANSHINONE;

ANIMAL; AORTA; ARTICLE; CELL CULTURE; CELL CYCLE; CELL PROLIFERATION; CYTOLOGY; DOWN REGULATION; DRUG EFFECT; GENE EXPRESSION; GENETICS; METABOLISM; RAT; SMOOTH MUSCLE FIBER;

ANIMALS; AORTA; CELL CYCLE; CELL PROLIFERATION; CELLS, CULTURED; DOWN-REGULATION; GENE EXPRESSION; MYOCYTES, SMOOTH MUSCLE; PHENANTHRENES; PROTO-ONCOGENE PROTEINS C-FOS; RATS;

EID: 56049111397     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Bennett M R, O Sullivan M. Mechanisms of angioplasty and stent restenosis: implications for design of rational therapy[J]. Pharmacol Ther, 2001, 91:149.
2. Indolfi C, Mongiardo A, Curcio A, et al. Molecular mechanisms of in-stent restenosis and approach to therapy with eluting stems [J]. Trends Cardiovasc Med, 2003, 13:142.
3. Chinese source
4. Chinese source
5. Chinese source
6. Chinese source
7. Chinese source
8. Lanza G M, Yu X, Winter P M, et al. Targented antiproliferative drug delivery to vascular smooth muscle cells with a magnetiv resonance imaging nanoparticle contrast agent: implications for rational therapy of restenosis[J]. Circulation, 2002, 106(22): 2842.
9. Bornfeldt K E. Intraceilular signaling in arterial smooth muscle migration versus proliferation[J]. Trends Cardiovasc Med, 1996, 6:143.
10. Porter A C, Vaillancourt R R. Tyrosine kinase receptor-activated signal transduction pathways which lead to oncogenesis[J]. Oncogene, 1998, 17:1343.
11. Tresisman R. Regulation of transcription by MAP kinase cascades [J]. Curr Opin Cell Biol, 1996, 8:205.
12. Muller D W. The role of proto-oncogenes in coronary restenosis [J]. Prog Cardiovasc Dis, 1997, 40:117.
13. Nagata N, Niwa Y, Nakaya Y. Anovel 31-amino-acid-length endothlin. ET-1 (1-31), can act as a biologically active peptide for vascular smooth muscle cells[J]. Biochem Biophys Res Commun, 2000, 275:595.